[Immunotherapy for HIV carrier].
Gohchi
K
K
Department of Medicine, Teikyo University School of Medicine.
Matsuda
J
J
D002353:Carrier State / Q000628:therapy*; D004050:Ditiocarb / Q000627:therapeutic use; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D019695:Glycyrrhizic Acid; D015658:HIV Infections / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007542:Inosine Pranobex / Q000627:therapeutic use; D007912:Lentinan / Q000627:therapeutic use; D011070:Poly I-C / Q000627:therapeutic use; D011072:Poly U / Q000627:therapeutic use
D004365:Drugs, Chinese Herbal; D011072:Poly U; D007912:Lentinan; D019695:Glycyrrhizic Acid; C047490:poly(I).poly(c12,U); D004050:Ditiocarb; D011070:Poly I-C; D006034:Glycyrrhetinic Acid; D007542:Inosine Pranobex